Kuwait has, separately, granted emergency use of the Pfizer vaccine. The state-run Bahrain news agency said the Sinopharm vaccine will be available off the coast of Saudi Arabia in the Persian Gulf in the island kingdom. However, it gave little information on the study results of the vaccine, in line with the United Arab Emirates, which declared that the vaccine was 86 percent successful last week. There were few specifics in the Emirati declaration, but the first official release of information on the effectiveness of the shot was
Bahrain said more than 7,700 people signed up to enroll in the kingdom’s Sinopharm vaccine trial. The kingdom has recently said it plans to offer free coronavirus vaccines to the public, but any concerns about its policy are yet to be addressed.
A few countries have licensed the Sinopharm vaccine for emergency use and the firm is also running late-stage clinical trials in 10 countries. Morocco is planning for an aggressive COVID-19 vaccination campaign that seeks to vaccinate 80% of its adults in an operation initially focused on the Sinopharm vaccine beginning this month.
Similar to how polio immunizations are made, Sinopharm’s shot depends on a proven technology using a killed virus to administer the vaccine. Leading Western rivals are using newer, less-proven technologies to attack the spike protein of the coronavirus using RNA, including the shot made by Pfizer and its German partner BioNTech. The United Kingdom has already started vaccinating individuals with the Pfizer injection, and the United States looks poised to suit shortly.
Pfizer already records its shot as being 95 percent successful, while Moderna’s other RNA candidate seems to be 94.5 percent effective. Results show that Oxford University and AstraZeneca’s third vaccine is safe and about 70 percent effective, but there are still concerns about how much it will help protect those over 55.
Kuwait’s state-run KUNA news agency reported on Sunday that the Ministry of Health of the oil-rich nation had granted emergency use of the Pfizer vaccine. The Ministry has also given people the opportunity to pre-register on its website to obtain the vaccine.
You have reached your limit for free articles this month.
Subscription Benefits Include
Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.
Enjoy reading as many articles as you wish without any limitations.
A select list of articles that match your interests and tastes.
Move smoothly between articles as our pages load instantly.
A one-stop-shop for seeing the latest updates, and managing your preferences.
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.